335832
Impact of HCBS Spending on Nursing Home Admissions for 1915(c) Waiver Enrollees
Methods
The Medicaid Analytic Extract Personal Summary File (24 states) and the NH Minimum Dataset were merged at the beneficiary level.
Individual-level outcomes of interest were time from HCBS waiver enrollment to long-term (90+ days) NH admission, functional (29 point Activities of Daily Living [ADL]) and cognitive (7 point Cognitive Performance Scale [CPS]) impairment at admission. An overall measure of impairment was also created and categorized as low (ADL<17 and CPS<3) vs other states.
Key independent variable was state-level average monthly HCBS spending per waiver enrollee, adjusted using area wage index. Individual, county, and state-level covariates were included.
We employed proportional hazards regressions with county clustering, mixed models with county random effects, and logit models with county random effects.
158,358 dual-eligible beneficiaries, age 65+, who entered 1915(c) aged or aged and disabled waiver programs in 24 states April 2005 - December 2007, were followed through 2009. 27,692 experienced subsequent long-term NH admission.
Results
An additional $1000 per month in average HCBS spending on waiver enrollees was associated with a 12% lower risk of long term NH admission (p=0.01), 0.91 higher functional impairment at admission (p<0.0001), and 15% lower odds of having overall low impairment at admission (p=0.001).
Higher per enrollee HCBS spending for waiver enrollees is associated with lower risk of, and greater impairment at, long-term NH admission.
Learning Areas:
Provision of health care to the publicPublic health or related public policy
Learning Objectives:
Describe methods of measuring and comparing the impact of home and community based services (HCBS) programs on nursing home admissions.
Keyword(s): Long-Term Care, Medicaid
Qualified on the content I am responsible for because: I have 20 years experience researching in this area.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.